Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (859)	11/16/1998 5:53:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 887

DepoCyt Approved!!!!!!! biz.yahoo.com John de C

To: StockDoc who wrote (859)	11/16/1998 6:10:00 PM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 887

DepoCyt Approval means tomorrow should be a very good day for DEPO. The SKYEY deal calls for an additional .106 SKYEY ADS per share for DepoCyt launch. At the current close of SKYEY of 11 7/8. This suggests an increase in DEPO value of 1 1/4. So, a pop of at least that much should occur. Currently the deal calls for .186 SKYEY ADS per DEPO share plus the .106 for the approval, or .292. This translates to .292 X 11 7/8 = $3.47. In addition, Skyey, itself should be lifted by the news. This should in turn create an even greater pop in DEPO. Also, this is a vindication of DepoFoam technology. ODAC approval means that the platform on which DEPO is based has the official seal of approval of a panel of experts. This should increase the perceived technology value of DEPO to the investment community in general. Tomorrow should be fun. John de C